John Yung
Stock Analyst at Citi
(0.64)
# 3,788
Out of 4,356 analysts
25
Total ratings
12.5%
Success rate
-7%
Average return
Main Sectors:
Stocks Rated by John Yung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1093 CSPC Pharmaceutical Group Limited | Maintained: Buy | $11.50 | $7.50 | +53.33% | 4 | May 28, 2026 | |
| HKG: 2196 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Maintained: Buy | $35.30 | $17.02 | +107.40% | 2 | Oct 29, 2025 | |
| HKG: 2005 SSY Group Limited | Maintained: Buy | $7.00 → $5.00 | $2.33 | +114.59% | 2 | Sep 5, 2025 | |
| HKG: 2273 Gushengtang Holdings Limited | Maintained: Buy | $55.00 | $27.90 | +97.13% | 3 | Sep 1, 2025 | |
| HKG: 1513 Livzon Pharmaceutical Group Inc. | Maintained: Buy | $48.00 | $26.28 | +82.65% | 1 | Aug 26, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $35.00 → $40.00 | $35.12 | +13.90% | 2 | Aug 21, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Maintained: Buy | $32.00 → $45.00 | $31.94 | +40.89% | 2 | Aug 20, 2025 | |
| HKG: 2268 WuXi XDC Cayman Inc. | Maintained: Buy | $41.00 → $70.00 | $54.90 | +27.50% | 2 | Aug 20, 2025 | |
| HKG: 1177 Sino Biopharmaceutical Limited | Maintained: Buy | $8.80 → $10.80 | $4.99 | +116.43% | 2 | Aug 19, 2025 | |
| HKG: 0241 Alibaba Health Information Technology Limited | Maintained: Buy | $8.50 | $3.63 | +134.16% | 1 | Jul 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74.00 | $130.40 | n/a | 1 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 → $38.90 | $18.32 | n/a | 2 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62.00 | $83.35 | n/a | 1 | Nov 10, 2023 |
CSPC Pharmaceutical Group Limited
May 28, 2026
Maintained: Buy
Price Target: $11.50
Current: $7.50
Upside: +53.33%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Oct 29, 2025
Maintained: Buy
Price Target: $35.30
Current: $17.02
Upside: +107.40%
SSY Group Limited
Sep 5, 2025
Maintained: Buy
Price Target: $7.00 → $5.00
Current: $2.33
Upside: +114.59%
Gushengtang Holdings Limited
Sep 1, 2025
Maintained: Buy
Price Target: $55.00
Current: $27.90
Upside: +97.13%
Livzon Pharmaceutical Group Inc.
Aug 26, 2025
Maintained: Buy
Price Target: $48.00
Current: $26.28
Upside: +82.65%
WuXi Biologics (Cayman) Inc.
Aug 21, 2025
Maintained: Buy
Price Target: $35.00 → $40.00
Current: $35.12
Upside: +13.90%
Hansoh Pharmaceutical Group Company Limited
Aug 20, 2025
Maintained: Buy
Price Target: $32.00 → $45.00
Current: $31.94
Upside: +40.89%
WuXi XDC Cayman Inc.
Aug 20, 2025
Maintained: Buy
Price Target: $41.00 → $70.00
Current: $54.90
Upside: +27.50%
Sino Biopharmaceutical Limited
Aug 19, 2025
Maintained: Buy
Price Target: $8.80 → $10.80
Current: $4.99
Upside: +116.43%
Alibaba Health Information Technology Limited
Jul 4, 2025
Maintained: Buy
Price Target: $8.50
Current: $3.63
Upside: +134.16%
Dec 27, 2024
Maintained: Buy
Price Target: $74.00
Current: $130.40
Upside: n/a
Aug 30, 2024
Maintained: Buy
Price Target: $40.00 → $38.90
Current: $18.32
Upside: n/a
Nov 10, 2023
Maintained: Buy
Price Target: $62.00
Current: $83.35
Upside: n/a